Le Lézard
Classified in: Health, Business, Covid-19 virus
Subjects: SRI, CFG

Government of Canada invests millions into mental health and distress centres


Distress centres experiencing a surge in demand with the impacts of COVID-19 on mental health

OTTAWA, ON, June 11, 2021 /CNW/ - Canadians are reporting an increase in stress, anxiety, depression, and loneliness. In fact, almost half of all Canadians have reported that their mental health has worsened since the beginning of the COVID-19 pandemic. Distress centres are a vital part of our community providing mental health support and resources to those in need. Across the country, these centres are seeing a surge in demand for mental health services.

Today, the Honourable Patty Hajdu, Minister of Health, announced an investment of $9,275,000 in 57 distress centres in Canada through the Public Health Agency of Canada. This investment will support a range of distress centres across the country, including in rural and remote areas. It will also support centres that provide crisis support for specific populations?including seniors, Indigenous communities, LGBTQ2 populations and racially and linguistically diverse communities. Project funding will support recruitment, training, operating costs, and knowledge exchanges.  

This is part of a $50 million investment first announced in the 2020 Fall Economic Statement to support distress centres across Canada during the COVID-19 pandemic. A second solicitation will be launched in the months ahead to provide funding to additional centres. A portion of these funds will support the development of resources that assist distress centres in meeting the needs of vulnerable populations during the pandemic.

All Canadians, including those who are at-risk and those living in rural and remote areas, need access to critical health and mental health resources and services. As we work with provinces and territories on expanding virtual services, we are making sure that Canadians can use emergency supports when they need them.

The Government is committed to supporting Canadians and their mental health through the COVID-19 pandemic and beyond. If you or a loved one is struggling, you can access the Wellness Together Canada portal, or call 1-866-585-0445 or text WELLNESS to 741741 (adults) or 686868 (youth).

Quotes

"The COVID-19 pandemic has had an impact on all of us. Many are experiencing new or worsened mental health challenges during these times, and we are taking action to help Canadians in crisis. If you need help, know that you are not alone. This critical support will help distress centres offer assistance across the country, and boost other investments to improve mental health services. Connecting Canadians to appropriate supports and resources will have substantial benefits and will help those in crisis."

The Honourable Patty Hajdu
Minister of Health

Quick Facts

Related Products

Associated Links

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 23:00
GenScript, a global leader in life sciences and biotechnology, successfully hosted an Open Day event at its Singapore facility on the 16th of April, welcoming more than 50 representatives from Singapore. This event provided an exclusive look into...

at 23:00
Cybervation, an award-winning global technology and healthcare solutions company, proudly announces that its CEO, Purba Majumder, has been distinguished as one of the 2024 100 Women to KNOW Across America. This award from KNOW Women recognizes...

at 22:33
The report titled "Glycated Albumin Assay Market by Product (Animal Glycated Albumin Assay, Human Glycated Albumin Assay), Application (Prediabetes, Type 1 Diabetes, Type 2 Diabetes), End User - Global Forecast 2024-2030" is now available on...

at 22:03
The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat & Eat), Nature (Genetically Modified Organism Food, Non-Genetically Modified Organism Food), Fat Content, Category, Free From Category,...

at 21:27
Hanmi Pharmaceutical (KOSPI: 128940, CEO: Jae-Hyun Park), a leading biopharma company in Korea that focuses on research areas such as oncology, obesity/metabolism, and rare diseases, announced it has entered into a Clinical Trial Collaboration and...

at 19:30
Astellas Pharma Inc....



News published on and distributed by: